Condition: Hemophilia A · Sponsor: Gritgen Therapeutics Co., Ltd.
This study is a single-arm, open-label, multicenter study evaluating the efficacy and safety of GS1191-0445 injection as a single dose in Chinese subjects with hemophilia A. GS1191-0445 is an AAV8-based gene therapy vector designed to express B-domain deleted human factor VIII (FVIII) under the regulation of a human liver-specific promoter. Following a single intravenous administration, AAV8 targets hepatocytes and facilitates the specific expression and secretion of FVIII into the bloodstream.
This description comes directly from the study's public registry record.
Yanfang Li · +8613817454595 · yanfang.li@gritgen.com
Always discuss trial participation with your own doctor first.
| Anhui Provincial Hospital | Hefei, Anhui, China | Not Yet Recruiting |
| Peking Union Medical College Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| First Hospital of Lanzhou University | Lanzhou, Gansu, China | Not Yet Recruiting |
| Nanfang Hospital Southern Medical University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| North China University of Science and Technology Affiliated Hospital | Tangshan, Hebei, China | Not Yet Recruiting |
| Henan Cancer Hospital | Zhengzhou, Henan, China | Not Yet Recruiting |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan, Hubei, China | Not Yet Recruiting |
| Xiangya Hospital of Central South University | Changsha, Hunan, China | Not Yet Recruiting |
| Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School | Nanjing, Jiangsu, China | Not Yet Recruiting |
| Jiangxi Provincial People's Hospital | Nanchang, Jiangxi, China | Not Yet Recruiting |
| Central Hospital Affiliated to Shandong First Medical University | Jinan, Shandong, China | Recruiting |
| Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College | Tianjin, Tianjin Municipality, China | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06833983